-
IPO GMP Race: Zetwerk vs Sahajanand Medical, Bonfiglioli and Tonbo Imaging
- October 19, 2026
- Posted by: Neeraj Pandey
- Category: News
No Comments
IPO GMP race: Zetwerk, Sahajanand Medical, Bonfiglioli and Tonbo Imaging compared on terms, valuation, subscription and risks, without unofficial figures.
-
Zetwerk IPO Day 3: Subscription Closes Today, 19 October 2026
- October 19, 2026
- Posted by: Harsh Piplani
- Category: IPO
Zetwerk IPO closes today. Day 3 subscription status and how to apply before the window shuts.
-
Zetwerk IPO Day 2: Subscription Status on 16 October 2026
- October 16, 2026
- Posted by: Harsh Piplani
- Category: IPO
Zetwerk IPO Day 2 subscription update for 16 October 2026, with category wise bidding trends and how to apply.
-
Zetwerk IPO Day 1: Subscription Opens Today, 15 October 2026
- October 15, 2026
- Posted by: Harsh Piplani
- Category: IPO
Zetwerk IPO opens today. Day 1 subscription status, price band, lot size and how to apply.
-
Zetwerk IPO: One-of-a-Kind Manufacturing Platform With a Profitability Problem
- October 14, 2026
- Posted by: Chaitanya Auti
- Category: News
Zetwerk IPO opens 15 Oct 2026 at Rs 143 to Rs 151. See dates, valuation, the Rs 1,606 crore FY26 loss, use of proceeds, strengths and risks.
-
Zetwerk IPO Valuation Targets Rs 25,583 Crore in Rs 5,012 Crore IPO: Price Band Rs 143 to Rs 151, Fresh Issue Rs 2,830 Crore, Revenue Rs 15,913 Crore, Losses, Use of Proceeds and What Investors Should Check
- October 12, 2026
- Posted by: Neeraj Pandey
- Category: News
Zetwerk IPO valuation is Rs 25,583 crore at the upper band. See the fresh issue, sellers, revenue, losses, use of proceeds and risks.
-
IPO GMP: Bonfiglioli vs Tonbo vs Sahajanand Medical vs Zetwerk, Dates, Price Band, Issue Size, Lot Size and Key Details of Four IPOs Opening 15 October With Rs 8,873 Crore in Total
- October 12, 2026
- Posted by: Lakshit Sharma
- Category: News
IPO GMP and key details of four IPOs opening 15 October: Bonfiglioli, Tonbo, Sahajanand Medical and Zetwerk. Compare price band, size and risks.